1.Зокирова М.Б. Нуриллаева Н.М. «Клинико-диагностическое значение эндогенных факторов фибринолиза у больных cишемической болезнью сердца»: автореф. дис..канд.мед.наук: 14.00.06 -Кардиология; 2024.2.3.Lowe GDO, Smith WCS, Tunstall-Pedoe HD, Crombie IK, Lennie SE, Anderson J, Barbenel JC. Cardiovascular risk and haemorheology: results from the Scottish Heart Health Study and the MONICA Project, Glasgow.Clin Hemorheol.1988;8:518–5244.Lee AJ, Fowkes GR, Lowe GDO, Rumley A. Determinants of fibrin D-dimer in the Edinburgh Artery Study.Arterioscler Thromb Vasc Biol.1995;15:1094–10975.Eliasson M, Asplund K, Evrin P-E, Lundblad D. Relationship of cigarette smoking and snuff dipping to plasma fibrinogen, fibrinolytic variables and serum insulin: the Northern Sweden MONICA Study. Atherosclerosis.1995;113:41–536.Conlan NG, Folsom AR, Finch A, Davis CE, Sorlie P, Marcucci G, Wu KK. Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Study.Thromb Haemost.1998;79:129–1337.Lowe GDO, Yarnell JWG, Sweetnam PM, Rumley A, Thomas HF, Elwood PC. Fibrin D-dimer, tissue plasminogen activator, plasminogen activator inhibitor, and the risk of major ischemic heart disease in the Caerphilly study.Thromb Haemost.1998;79:129–1338.Rumley A, Lowe GDO, Sweetnam PM, Yarnell JWG, Thomas HF, Ford RP. Factor VIII, von Willebrand factor and the risk of major ischemic heart disease in the Caerphilly Study.Br J Haematol..1999;105:110–1169.Meade TW, Imeson J, Stirling Y. Effect of changes in smoking and other characteristics on clotting factors and the risk of ischemic heart disease.Lancet.1987;2:986–98810.BeagleholeR, Jackson R. Alcohol, cardiovascular diseases and all causes of death: a review of the epidemiological evidence.Drug Alcohol Rev.1992;11:275–29011.Ridker PM, Vaughan DE, Stampfer MJ, Glynn RJ, Hennekens CH. Association of moderate alcohol consumption and plasma concentration of endogenous tissue type plasminogen activator.JAMA.1994;272:929–93312.Lee AJ, Flanagan PA, Rumley A, FowkesFGR, Lowe GDO. Relationship between alcohol intake and tissue-plasminogen activator antigen and other hemostatic factors in the general population.Fibrinolysis.1995;9:49–5413.Smith FB, Lee AJ, Fowkes FGR, Price JF, Rumley A, Lowe GDO. Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study.Arterioscler Thromb Vasc Biol.1997;17:3321–332514.Nilsson TK, Jansson JH, Boman K. t-PA–PAI-1 complex as a risk factor for the development of a first stroke.Fibrinolysis. 1998;12(suppl 1):21. Abstract15.Hendriks HF, Veenstra J, Velthuis-te Wierik EJ, Schaafsma G, Kluft C. Effect of moderate dose of alcohol with evening meal on fibrinolytic factors.BMJ.1994;308:1003–1006.16.Collins R, MacMahon S, Flather M, Baigent C, Remvig L, Mortensen S, Appleby P, Godwin J, Yusuf S, Peto R. Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trials.BMJ.1996;313:652–659.